Publications in collaboration with researchers from Centro de Investigaciones Biológicas (15)

2023

  1. Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy

    Kidney360, Vol. 4, Núm. 5, pp. 659-672

2022

  1. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy

    Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 6, pp. 1137-1153

  2. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280

2021

  1. Validation of a Histologic Scoring Index for C3 Glomerulopathy

    American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1

2020

  1. Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease

    Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298

2019

  1. Secondary atypical hemolytic uremic syndromes in the era of complement blockade

    Kidney International

  2. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome

    Kidney International, Vol. 96, Núm. 4, pp. 995-1004

  3. The authors reply

    Kidney International

2018

  1. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome

    Kidney International, Vol. 93, Núm. 2, pp. 450-459

2017

  1. Eculizumab in secondary atypical haemolytic uraemic syndrome

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 466-474

  2. Elevated factor H–related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy

    Kidney International, Vol. 92, Núm. 4, pp. 953-963

2016

  1. Atypical hemolytic uremic syndrome (aHUS): Essential aspects of an accurate diagnosis

    Clinical Advances in Hematology and Oncology, Vol. 14, Núm. 11, pp. 2-15

2015

  1. An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document

    Nefrologia

  2. Effectiveness of mycophenolate mofetil in C3 glomerulonephritis

    Kidney International, Vol. 88, Núm. 5, pp. 1153-1160

2013

  1. An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document

    Nefrologia, Vol. 33, Núm. 1, pp. 27-45